Top 20 of Ascites

Article title # Publications/# Citations

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

2004: XAlvarez; MBurow; LChen; PCheng; JRConejo-Garcia; GCoukos; TJCuriel; BDaniel; ... MLDisis; MEvdemon-Hogan; AGordon; KLKnutson; IKryczek; ALackner; PMottram; LMyers; SWei; LZhang; YZhu; LZou; WZou;

684

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

1983: AMDvorak; HFDvorak; SJGalli; VSHarvey; CAPerruzzi; DRSenger;

417

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

2002: THeike; KHioki; HHiramatsu; MIto; MKawahata; KKobayashi; YKoyanagi; TNakahata; ... KSugamura; KSuzue; KTsuji; YUeyama;

194

Primary bioassay of human tumor stem cells.

1977: AWHamburger; SESalmon;

173

Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus.

1979: MJBevan; PFink; MLGefter; TGridley; AMarshak-Rothstein; DHRaulet;

158

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

2000: FDGordon; PSKamath; MMalinchoc; CJPeine; JRank; PCter Borg;

155

Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

1996: MQAnsari; ECesarman; AChadburn; DBDawson; DMKnowles; RGNador; JSald;

125

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.

2009: CYChen; JADoudna; TFDuchaine; MRFabian; WFilipowicz; GJHannon; MJinek; GMathonnet; ... HMathys; FRivas; ABShyu; NSonenberg; TSundermeier; YVSvitkin; JWohlschlegel; JRYates; JTZipprich;

112

Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency.

1965: DWDresser; DHWortis;

92

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1988 Sep-Oct: VArroyo; MBernardi; MEpstein; JHHenriksen; JRodés; RWSchrier;

89

Ovarian cancer metastasis: integrating insights from disparate model organisms.

2005: DJMontell; HNaora;

86

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.

2000: CArvieux; JBaulieux; ACBeaujard; ABrachet; JLCaillot; JLFaure; EFontaumard; YFrancois; ... FNGilly; OGlehen; JLPeix; JPorcheron; MRivoire; BSadeghi; JVignal;

81

Telomerase activity in human ovarian carcinoma.

1994: SBacchetti; CMCounter; CBHarley; HWHirte;

79

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

1996: VArroyo; FJDudley; PGentilini; ALGerbes; PGines; GLaffi; TBReynolds; HRing-Larsen; JSchölmerich;

76

Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line.

1975: INakoinz; PRalph;

67

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

2000: HBender; JLBenedet; HJones; HYNgan; SPecorelli;

64

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

2005: XAlvarez; PCarmeliet; PCheng; TJCuriel; DEmilie; MHogan; IKryczek; ALackner; ... ALange; VMachelon; LMoons; PMottram; MTerrassa; SWei; LZou; WZou;

62

Regulatory mechanisms in carbohydrate metabolism. III. Limiting factors in glycolysis of ascites tumor cells.

1959: ERacker; RWu;

62

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

2000: BBernard; GGarcia-Tsao; JMInadomi; MNavasa; LJPiddock; RPlanas; ARimola;

60

Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes.

1959: PBarrow; BGoldberg; HGreen;

58